XBIO

Conviction 49HealthcareScan · Mon, Aug 10, 2026

XBIO$3.07-3.15%

ResistanceSupportVol 14

Vol MA14 87.6K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Xenetic Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.xeneticbio.com ↗

Price3.07

Change-3.15%

Gap-2.21%

Rel volume0.03×

Avg volume67.24K

Avg $ vol201.96K

SMA 202.75

SMA 502.90

SMA 2002.74

Price vs 50+5.85%

Price vs 200+11.96%

MA stackbullish

50/200 cross—

Supertrendup · 2.48

RSI (14)60

MACD hist0.07

MACD crossbull · 4d

Stoch %K / %D80 / 83

ADX (14)19

+DI / −DI27 / 13

RSI divergence—

MACD divergence—

ATR %+6.61%

ADR %6.99%

52w high10.36

52w low2.02

From 52w high-70.37%

Above 52w low+51.98%

New 52w highNo

SqueezeOff

Bollinger width28.07%

%B0.91

Donchian pos79.55%

Donchian high3.25

Donchian low2.37

AVWAP (52w high)9.99

vs AVWAP high-69.26%

AVWAP (52w low)2.77

vs AVWAP low+10.88%

OBV trendUp

Chaikin MF (20)0.41

Today vs 20d0.03×

Avg vol (14d)87.59K

Avg vol (20d)67.24K

Avg $ vol (20d)201.96K

Market cap7.19M

RS 3m (vs SPY)-4.09%

RS 6m (vs SPY)+38.29%

RS line new highNo

Trend template5/8

Technical rank81.1

1 week+15.41%

1 month+12.25%

3 months+0.00%

6 months+47.60%

1 year+3.37%

YTD+42.79%

P/E-2.68

P/B1.18

P/S2.42

P/FCF-3.15

EPS-1.58

Div yield—

ROE-44.14%

ROA-38.47%

Debt/Eq0.10

Current7.43

EV/EBITDA-0.47

Gross margin0.00%

Net margin-90.07%

Rev growth19.04%

EPS growth32.31%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value1.31M

Revenue660.6K

Net income-929.7K

Gross profit0

Free cash flow-2.29M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees2

ListedWed, May 16, 2012

Free float1.96M

Float %85.5%

Short interest19.29K

Days to cover1.2d

Short volume11.1%

Squeeze score8 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank81.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.09

Support2.52

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XBIO

All disclosures →

No recent disclosed trades by Congress in XBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XBIO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
PARSLOW JAMES F Interim CEO and CFO · Common Stock · 2026-04-21	Grant	100K	$0	2026-04-21	2026-04-23

SEC filings

EDGAR filings in XBIO · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.